Back to Use Cases
Human
Drug Design
Molecular Docking
BCR-ABL
Imatinib
AutoDock Vina
Imatinib (Gleevec) — BCR-ABL Kinase Inhibitor Drug Design Analysis
Complete computational drug design pipeline: PubChem compound retrieval, ADMET profiling, AlphaFold structure fetch, fpocket binding site detection, and AutoDock Vina molecular docking — confirming Imatinib as a strong BCR-ABL binder at -9.4 kcal/mol.
Download PDFCan't see the report? Open the PDF directly or download it.
Run Your Own Analysis
Upload your data and describe your experiment. Pipette handles the entire pipeline.
Get Started Free